# Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)

> **NCT02439567** · NA · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 41 (actual)

## Conditions studied

- Chronic Hepatitis C
- Cirrhosis
- Portal Hypertension

## Interventions

- **DEVICE:** Fibroscan: Liver and Spleen elastography

## Key facts

- **NCT ID:** NCT02439567
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02439567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02439567, "Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02439567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*